IP Library Granted Patent US 11,155,868
Granted Patent B2
US 11,155,868 · App. 17/155,226 · Granted Oct 26, 2021

Methods, devices, and systems for analyte detection and analysis

Inventors: Gilad Almogy (Palo Alto, CA); Nathan Beckett (Oakland, CA); Jacob A. Wolf (Oakland, CA); Nathan Caswell (Sunnyvale, CA); Joseph Anthony (Oakland, CA); Jose Martin Sosa (San Jose, CA); Phillip Lee (South San Francisco, CA); Stephanie Kubecka (San Jose, CA)
Assignee: ULTIMA GENOMICS, INC.
C12Q1/6874B01J19/0046B01L3/502715C12Q1/6809C12Q1/6825B01J2219/00536B01J2219/00596B01J2219/00689B01J2219/00702B01J2219/00722B01L2200/0647B01L2300/0654B01L2400/0409
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,155,868
App. No.
17/155,226
Granted
Oct 26, 2021
Kind
B2
Abstract

Provided are systems and methods for analyte detection and analysis. A system can comprise an open substrate. The open substrate may be configured to rotate or otherwise move. The open substrate can comprise an array of individually addressable locations, with analytes immobilized thereto. The substrate may be spatially indexed to identify nucleic acid molecules from one or more sources, and/or sequences thereof, with the respective one or more sources. A solution comprising a plurality of probes may be directed across the array to couple at least one of the plurality of probes with at least one of the analytes to form a bound probe. A detector can be configured to detect a signal from the bound probe via scanning of the substrate while minimizing temperature fluctuations of the substrate or optical aberrations caused by bubbles.

Claims (38)

1. A method for nucleic acid sample processing, comprising:

(a) providing a substrate, a first source comprising a first set of nucleic acid molecules, and a second source comprising a second set of nucleic acid molecules, wherein said first source is different than said second source, wherein said substrate comprises a first region and a second region different from said first region, wherein said first region or said second region comprises at least 10,000 indexed locations;

(b) directing said first set of nucleic acid molecules from said first source to said first region under conditions sufficient to immobilize said first set of nucleic acid molecules to a first set of locations in said first region, thereby indexing said first set of locations to said first source;

(c) directing said second set of nucleic acid molecules from said second source to said second region under conditions sufficient to immobilize said second set of nucleic acid molecules to a second set of locations in said second region, thereby indexing said second set of locations to said second source;

(d) detecting (i) signals from said first region that are indicative of at least one nucleotide having been incorporated into a growing nucleic acid strand that is complementary to a nucleic acid molecule of said first set of nucleic acid molecules, thereby determining a first set of sequences of said first set of nucleic acid molecules and (ii) signals from said second region to determine a second set of sequences of said second set of nucleic acid molecules; and

(e) using (1) said first set of sequences determined from signals detected from said first region and said indexed first set of locations to associate said first set of sequences to said first source and (2) said second set of sequences determined from signals detected from said second region and said indexed second set of locations to associate said second set of sequences to said second source.

2. The method of claim 1 , wherein said first set of sequences are associated with said first source and said second set of sequences are associated with said second source in (e) in absence of determining a barcode sequence of said first set of nucleic acid molecules and said second set of nucleic acid molecules.

3. The method of claim 1 , wherein each nucleic acid molecule of said first set of nucleic acid molecules and said second set of nucleic acid molecules comprises a synthetic sequence of no more than 6 bases in length, wherein a subset of nucleic acid molecules originating from a same source each comprises a common synthetic sequence, which common synthetic sequence is different from synthetic sequences of another subset of nucleic acid molecules originating from a different source.

4. The method of claim 1 , wherein said substrate comprises a plurality of binders, wherein a binder of said plurality of binders is capable of immobilizing both nucleic acid molecules from said first set of nucleic acid molecules and nucleic acid molecules from said second set of nucleic acid molecules, wherein said first set of nucleic acid molecules is immobilized to said first set of locations via a first set of binders of said plurality of binders and wherein said second set of nucleic acid molecules is immobilized to said second set of locations via a second set of binders of said plurality of binders different from said first set of binders.

5. The method of claim 4 , wherein said binder is configured to immobilize said first set of nucleic acid molecules and said second set of nucleic acid molecules using one or more interactions selected from a group consisting of: hydrophilic interactions, hydrophobic interactions, electrostatic interactions, and hybridization interactions.

6. The method of claim 1 , wherein said first region and said second region are adjacent and in contact on said substrate.

7. The method of claim 1 , wherein said substrate comprises (1) a plurality of first regions, including said first region, configured to receive nucleic acid molecules from said first source and (2) a plurality of second regions, including said second region, configured to receive nucleic acid molecules from said second source, which plurality of first regions and plurality of second regions are arranged on said substrate such that a given first region of said plurality of first regions is not in contact with another first region of said plurality of first regions.

8. The method of claim 7 , wherein said plurality of first regions and said plurality of second regions are arranged as alternating regions on said substrate.

9. The method of claim 8 , wherein said plurality of first regions and said plurality of second regions are arranged as radially alternating regions on said substrate.

10. The method of claim 7 , wherein (i) said plurality of first regions are chemically distinct from said plurality of second regions, or (ii) said plurality of first regions and said plurality of second regions are separated by barriers.

11. The method of claim 1 , wherein said first region and said second region are of different sizes or comprise different numbers of individually addressable locations on said substrate.

12. The method of claim 1 , wherein (b) and (c) comprise:

i. contacting said substrate with a first loading fluid comprising said first set of nucleic acid molecules and a second loading fluid comprising said second set of nucleic acid molecules, wherein said first loading fluid and said second loading fluid are immiscible;

ii. applying a magnetic field to direct said first set of nucleic acid molecules or said second set of nucleic acid molecules to said substrate; or

iii. (1) with said first region unmasked and said second region masked, directing said first set of nucleic acid molecules to said substrate; (2) unmasking said second region; and (3) with said second region unmasked, directing said second set of nucleic acid molecules to said substrate.

13. The method of claim 1 , wherein said first region and said second region are separated by a barrier on said substrate, wherein said barrier comprises a viscous solution, polyethylene glycol (PEG), a fluid that is immiscible with a loading solution comprising said first set of nucleic acid molecules and said second set of nucleic acid molecules, an air knife, an injection molded guide, or a hydrophobic region.

14. The method of claim 1 , wherein said substrate is substantially planar.

15. The method of claim 1 , wherein said substrate is patterned.

16. The method of claim 1 , wherein said directing in (b) and said directing in (c) are performed substantially simultaneously.

17. The method of claim 1 , wherein said directing in (c) is performed subsequent to said directing in (b).

18. The method of claim 1 , wherein (d) comprises sequencing.

19. The method of claim 1 , wherein (d) comprises detecting signals that are indicative of at least one nucleotide having been incorporated into a growing nucleic acid strand that is complementary to a nucleic acid molecule of said first set of nucleic acid molecules and said second set of nucleic acid molecules.

20. The method of claim 1 , wherein (d) further comprises rotating said substrate with respect to a rotational axis during said detecting.

21. The method of claim 1 , wherein (d) comprises dispersing one or more solutions across said substrate, wherein said one or more solutions comprise reagents configured to react with said first set of nucleic acid molecules and said second set of nucleic acid molecules.

22. The method of claim 21 , wherein (d) further comprises rotating said substrate with respect to a rotational axis, wherein said dispersing comprises movement of said reagents from a first location on said substrate to a second location on said substrate due to said rotating, wherein said first location and said second location have different radial distances from said rotational axis.

23. The method of claim 1 , wherein nucleic acid molecules of said first set of nucleic acid molecules have sequences that are different from nucleic acid molecules of said second set of nucleic acid molecules.

24. The method of claim 1 , wherein nucleic acid molecules of said first set of nucleic acid molecules have the same sequences as nucleic acid molecules of said second set of nucleic acid molecules.

25. The method of claim 1 , wherein, in (b), said first set of nucleic acid molecules is attached to a plurality of beads, which plurality of beads is immobilized adjacent to said substrate at said first set of locations.

26. The method of claim 25 , wherein a bead of said plurality of beads comprises a plurality of nucleic acid molecules attached thereto, wherein said plurality of nucleic acid molecules comprises amplification products derived from a nucleic acid molecule of said first set of nucleic acid molecules.

27. The method of claim 1 , wherein said first set of locations comprise at least 100 individually addressable locations, and wherein said second set of locations comprises at least 100 individually addressable locations.

28. The method of claim 1 , wherein said substrate comprises a plurality of individually addressable locations including said first set of locations and said second set of locations, and wherein an individually addressable location of said plurality of individually addressable locations is configured to associate with a nucleic acid molecule of said first set of nucleic acid molecules or said second set of nucleic acid molecules.

29. The method of claim 28 , wherein said plurality of individually addressable locations comprise at least 50,000,000,000 individually addressable locations.

30. The method of claim 28 , wherein said individually addressable location is configured to associate with a bead, wherein said bead comprises said nucleic acid molecule attached thereto, wherein said first set of nucleic acid molecules are attached to a first plurality of beads and wherein said second set of nucleic acid molecules are attached to a second plurality of beads, wherein, subsequent to (b) and (c), said first plurality of beads and said second plurality of beads are associated to said plurality of individually addressable locations.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2026
From: ULTIMA GENOMICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 075435/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2021
From: ALMOGY, GILAD; BECKETT, NATHAN; WOLF, JACOB A.; CASWELL, NATHAN; ANTHONY, JOSEPH; SOSA, JOSE MARTIN; LEE, PHILLIP; KUBECKA, STEPHANIE
To: ULTIMA GENOMICS, INC.
Reel/Frame 055089/0537 →
Continuity (4)
Continuation 16445798 · Jun 19, 2019
Provisional Application 62818549 · Mar 14, 2019
Provisional Application 62837684 · Apr 23, 2019
Related Publication 20210139980A1 · May 13, 2021
Cited By (4)
US 12,188,924 US 12,239,980 US 12,480,938 US 12,571,036